Advertisement
BSX vs NTRA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Buy and NTRA is a StrongBuy.
| BSX | NTRA | BSX / NTRA | |
| Capitalization | 62.3B | 47.4B | 131% |
| EBITDA | 5.64B | -183.08M | -3,079% |
| Gain YTD | -54.924 | 43.581 | -126% |
| P/E Ratio | 17.40 | N/A | - |
| Revenue | 21B | 2.71B | 776% |
| Total Cash | 539M | 1.09B | 49% |
| Total Debt | 12.6B | 238M | 5,294% |
BSX | NTRA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 69 | 22 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 52 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 17 | |
SMR RATING 1..100 | 55 | 94 | |
PRICE GROWTH RATING 1..100 | 65 | 35 | |
P/E GROWTH RATING 1..100 | 98 | 100 | |
SEASONALITY SCORE 1..100 | 85 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NTRA's Valuation (52) in the Biotechnology industry is in the same range as BSX (66) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to BSX’s over the last 12 months.
NTRA's Profit vs Risk Rating (17) in the Biotechnology industry is significantly better than the same rating for BSX (100) in the Medical Specialties industry. This means that NTRA’s stock grew significantly faster than BSX’s over the last 12 months.
BSX's SMR Rating (55) in the Medical Specialties industry is somewhat better than the same rating for NTRA (94) in the Biotechnology industry. This means that BSX’s stock grew somewhat faster than NTRA’s over the last 12 months.
NTRA's Price Growth Rating (35) in the Biotechnology industry is in the same range as BSX (65) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to BSX’s over the last 12 months.
BSX's P/E Growth Rating (98) in the Medical Specialties industry is in the same range as NTRA (100) in the Biotechnology industry. This means that BSX’s stock grew similarly to NTRA’s over the last 12 months.
| BSX | NTRA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 73% | 1 day ago 66% |
| Stochastic ODDS (%) | 1 day ago 63% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 49% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 59% | 1 day ago 71% |
| TrendWeek ODDS (%) | 1 day ago 54% | 1 day ago 81% |
| TrendMonth ODDS (%) | 1 day ago 61% | 1 day ago 82% |
| Advances ODDS (%) | 13 days ago 59% | 9 days ago 79% |
| Declines ODDS (%) | 1 day ago 54% | 12 days ago 77% |
| BollingerBands ODDS (%) | 1 day ago 62% | 4 days ago 60% |
| Aroon ODDS (%) | 1 day ago 56% | 1 day ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BSX’s FA Score shows that 0 FA rating(s) are green while NTRA’s FA Score has 1 green FA rating(s).
- BSX’s FA Score: 0 green, 5 red.
- NTRA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BSX’s TA Score shows that 5 TA indicator(s) are bullish while NTRA’s TA Score has 2 bullish TA indicator(s).
- BSX’s TA Score: 5 bullish, 5 bearish.
- NTRA’s TA Score: 2 bullish, 6 bearish.
Price Growth
BSX (@Medical/Nursing Services) experienced а -10.08% price change this week, while NTRA (@Medical Specialties) price change was +0.23% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.54%. For the same industry, the average monthly price growth was +4.08%, and the average quarterly price growth was +36.27%.
Reported Earning Dates
BSX is expected to report earnings on Oct 28, 2026.
NTRA is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Medical/Nursing Services (-5.01% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-3.54% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
NTRA and
Correlation & Price change
A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with ISRG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To NTRA | 1D Price Change % | ||
|---|---|---|---|---|
| NTRA | 100% | +0.86% | ||
| ISRG - NTRA | 53% Loosely correlated | +2.41% | ||
| ADPT - NTRA | 52% Loosely correlated | -0.12% | ||
| NEO - NTRA | 51% Loosely correlated | -1.65% | ||
| GH - NTRA | 50% Loosely correlated | -1.04% | ||
| PSNL - NTRA | 48% Loosely correlated | -0.73% | ||
More | ||||